PROTOCOL NRG-CC017

ACTIVATION


NRG-CC017: "A randomized phase III study comparing temporally-modulated pulsed radiation therapy (TMPRT) versus standard radiation therapy with temozolomide for adults with newly diagnosed MGMT-unmethylated glioblastoma" 

 

Activation Date: April 1, 2026

 

Documents are posted on the CTSU website.

 

Facebook  X  Instagram  LinkedIn  YouTube